====== Cycloheximide 0.2μM R00 exp15 ======
==== Mechanism of Action ====
Translation elongation inhibitor, binds 60S ribosomal subunit
* **Class / Subclass 1:** Proteostasis / Translation Inhibitor
* **Class / Subclass 2:** Environmental Stresses / Toxin
==== Technical Notes ====
* **PubChem Name:** %%Cycloheximide%%
* **Synonyms:** Naramycin A; Actidione; CHX
* **CAS #:** 66-81-9
* **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/6197|6197]]
* **IUPAC:** %%4-[(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]piperidine-2,6-dione%%
* **INCHI Name:** InChI=1S/C15H23NO4/c1-8-3-9(2)15(20)11(4-8)12(17)5-10-6-13(18)16-14(19)7-10/h8-12,17H,3-7H2,1-2H3,(H,16,18,19)/t8-,9-,11-,12+/m0/s1
* **INCHI Key:** YPHMISFOHDHNIV-FSZOTQKASA-N
* **Molecular Weight:** 281.35
* **Canonical SMILES:** CC1CC(C(=O)C(C1)C(CC2CC(=O)NC(=O)C2)O)C
* **Isomeric SMILES:** C[C@H]1C[C@@H](C(=O)[C@@H](C1)[C@@H](CC2CC(=O)NC(=O)C2)O)C
* **Molecular Formula:** C15H23NO4
{{:chemogenomics:structures:chem-0008.svg?nolink}}
* **Supplier Name:** Sigma-Aldrich
* **Catalog #:** C7698
* **Lot #:** MKBR7146V
* **HRMS (ESI-TOF) m/z:** (M+H)+ Calcd for C15H23NO4 282.16998; found 282.17004
* **Platform ID:** Cycloheximide
* **Min:** 3.7773; **Max:** 80.9065
{{:chemogenomics:dose_response:dr_261.png?nolink&500 |}}
\\
\\
\\
\\
|< 300px 100px 200px >|
^ IC ^ Concentration (µM) ^
| IC10 |N/A |
| IC20 |0.1270 |
| IC30 |0.3675 |
| IC40 |0.8782 |
| IC50 |1.9535 |
| IC60 |N/A |
| IC70 |N/A |
| IC80 |N/A |
| IC90 |N/A |
\\
==== Screen Summary ====
* **Round**: 00
* **Dose**: 200nM
* **Days of incubation**: 8
* **Doublings**: 5.6
* **Numbers of reads**: 9929747
==== Screen Results ====
^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^
|3/0|[[https://files.tyerslab.com/files/public/chemogenomics/cranks/Cycloheximide_0.2uM_Round-0_exp15.txt|Scores]]||||||
{{:chemogenomics:cranks_plots:exp15.png?nolink}}
^Gene^CRANKS Score^FDR^
|[[:human_genes:S:SETD6|SETD6]]|-4.60|<0.01|
|[[:human_genes:P:PRAMEF25|PRAMEF25]]|-3.41|0.27|
|[[:human_genes:P:PRAMEF26|PRAMEF26]]|-3.39|0.27|
|[[:human_genes:D:DDX39A|DDX39A]]|-3.09|<0.01|
|[[:human_genes:C:CD2BP2|CD2BP2]]|-2.76|0.02|
|[[:human_genes:L:LAMTOR4|LAMTOR4]]|-2.58|0.10|
|[[:human_genes:D:DDX6|DDX6]]|-2.53|0.07|
|[[:human_genes:A:AHCY|AHCY]]|-2.50|0.07|
|[[:human_genes:O:ORC3|ORC3]]|-2.38|0.21|
|[[:human_genes:C:CALML3|CALML3]]|-2.37|0.18|
|[[:human_genes:D:DYSF|DYSF]]|-2.32|0.15|
|[[:human_genes:S:SCO2|SCO2]]|-2.28|0.15|
|[[:human_genes:D:DRG2|DRG2]]|-2.28|0.15|
|[[:human_genes:P:PTRH2|PTRH2]]|-2.27|0.21|
|[[:human_genes:K:KRTAP10-3|KRTAP10-3]]|-2.23|0.21|
|[[:human_genes:C:CDK2|CDK2]]|-2.18|0.26|
|[[:human_genes:K:KRT71|KRT71]]|-2.15|0.21|
|[[:human_genes:O:ODC1|ODC1]]|-2.15|0.21|
|[[:human_genes:G:GGPS1|GGPS1]]|-2.12|0.30|
|[[:human_genes:F:FBXO11|FBXO11]]|-2.12|0.21|
|[[:human_genes:T:TOMM34|TOMM34]]|-2.12|0.21|
|[[:human_genes:A:ASB3|ASB3]]|-2.11|0.21|
|[[:human_genes:M:MEF2A|MEF2A]]|-2.08|0.35|
|[[:human_genes:C:CFAP45|CFAP45]]|-2.08|0.67|
|[[:human_genes:N:NEMF|NEMF]]|-2.07|0.35|
|[[:human_genes:T:TP53I13|TP53I13]]|-2.03|0.38|
|[[:human_genes:A:ATF7IP|ATF7IP]]|-2.02|0.28|
|[[:human_genes:D:DCAF15|DCAF15]]|-2.00|0.43|
|[[:human_genes:P:PRDM10|PRDM10]]|-1.99|0.44|
|[[:human_genes:Z:ZNF598|ZNF598]]|-1.95|0.46|
|[[:human_genes:T:TNFRSF10D|TNFRSF10D]]|2.15|0.27|
|[[:human_genes:P:PSMD1|PSMD1]]|2.15|0.55|
|[[:human_genes:Z:ZNF28|ZNF28]]|2.16|0.27|
|[[:human_genes:N:NSL1|NSL1]]|2.16|0.27|
|[[:human_genes:G:GPR183|GPR183]]|2.16|0.27|
|[[:human_genes:T:TIMM23B|TIMM23B]]|2.16|0.44|
|[[:human_genes:M:MPC2|MPC2]]|2.17|0.27|
|[[:human_genes:C:COPG1|COPG1]]|2.19|0.43|
|[[:human_genes:N:NUP153|NUP153]]|2.20|0.30|
|[[:human_genes:R:RRP1|RRP1]]|2.21|0.27|
|[[:human_genes:C:CCDC90B|CCDC90B]]|2.21|0.27|
|[[:human_genes:K:KRAS|KRAS]]|2.22|0.27|
|[[:human_genes:V:VASN|VASN]]|2.22|0.27|
|[[:human_genes:D:DNM2|DNM2]]|2.24|0.49|
|[[:human_genes:E:ELOVL5|ELOVL5]]|2.24|0.27|
|[[:human_genes:R:RPL8|RPL8]]|2.25|0.57|
|[[:human_genes:T:TMEM165|TMEM165]]|2.25|0.27|
|[[:human_genes:W:WDR43|WDR43]]|2.27|0.40|
|[[:human_genes:U:USP27X|USP27X]]|2.30|0.57|
|[[:human_genes:M:MARVELD1|MARVELD1]]|2.30|0.57|
|[[:human_genes:P:PSMD7|PSMD7]]|2.32|0.40|
|[[:human_genes:D:DDI2|DDI2]]|2.45|0.25|
|[[:human_genes:B:BCL2L1|BCL2L1]]|2.52|0.27|
|[[:human_genes:R:RPS6|RPS6]]|2.57|0.40|
|[[:human_genes:P:PLK4|PLK4]]|2.64|0.29|
|[[:human_genes:D:DTL|DTL]]|2.68|0.27|
|[[:human_genes:S:SCAF1|SCAF1]]|2.79|0.43|
|[[:human_genes:C:COL28A1|COL28A1]]|3.00|0.17|
|[[:human_genes:K:KIF11|KIF11]]|3.05|0.36|
|[[:human_genes:C:CKAP5|CKAP5]]|3.28|0.27|
^Screen^Correlation^Plot^
|[[:results:exp31|Rifampicin 1μM R00 exp31]]|0.071||
|[[:results:exp235|Geldanamycin 0.01μM R05 exp235]]|0.065||
|[[:results:exp32|Rifampicin 10μM R00 exp32]]|0.061||
|[[:results:exp29|Rapamycin 1μM R00 exp29]]|0.058||
|[[:results:exp38|Wortmannin 5μM R00 exp38]]|0.056||
|[[:results:exp10|CCCP 0.1μM R00 exp10]]|0.074||
|[[:results:exp1|5-Fluorouracil 2μM R00 exp1]]|0.059||
|[[:results:exp5|Alpha-Amanitin 0.5μM R00 exp5]]|0.051||
{{:chemogenomics:comparison_plots:exp15_vs_exp31.png?nolink |}}
{{:chemogenomics:comparison_plots:exp15_vs_exp235.png?nolink |}}
{{:chemogenomics:comparison_plots:exp15_vs_exp32.png?nolink |}}
{{:chemogenomics:comparison_plots:exp15_vs_exp29.png?nolink |}}
{{:chemogenomics:comparison_plots:exp15_vs_exp38.png?nolink |}}
{{:chemogenomics:comparison_plots:exp10_vs_exp15.png?nolink |}}
{{:chemogenomics:comparison_plots:exp1_vs_exp15.png?nolink |}}
{{:chemogenomics:comparison_plots:exp15_vs_exp5.png?nolink |}}
No GO term hits below threshold. (FDR <0.05)
No GO term hits below threshold. (FDR <0.05)